Molecular Nutrition & Food Research · 2008 · 141 citations · 32 references
Life SciencesBiochemistryPharmacologyCell SignalingMetabolismSignal TransductionDiabetes MellitusDiabetes Mellitus BiochemistryGlucose HomeostasisGlycogen MetabolismInsulin ResistanceInsulin Signaling In MetabolismAntidiabetic ActivityInsulin Receptor SignalingInsulin Receptor Substrate ProteinsInsulin Signal TransductionInsulin SignalingInsulin Signaling DisruptionInsulin Signaling PathwayLiver Insulin Signaling
Insulin resistance is the primary characteristic of type 2 diabetes which as a result of insulin signaling defects. It has been suggested that the tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) displays some antidiabetic effects, but the mechanism for EGCG insulin-enhancing effects is incompletely understood. In the present study, the investigations of EGCG on insulin signaling are performed in insulin-responsive human HepG2 cells cotreated with high glucose. We found that the high glucose condition causes significant increasing Ser307 phosphorylation of insulin receptor substrate-1 (IRS-1), leading to reduce insulin-stimulated phosphorylation of Akt. As the results, the insulin metabolic effects of glycogen synthesis and glucose uptake are inhibited by high glucose. However, the treatment of EGCG improves insulin-stimulated downsignaling by reducing IRS-1 Ser307 phosphorylation. Furthermore, we also demonstrated these EGCG effects are essential depends on the 5'-AMP-activated protein kinase (AMPK) activation. Together, our data suggest a putative link between high glucose and insulin resistance in HepG2 cells, and the EGCG treatment attenuates insulin signaling blockade by reducing IRS-1 Ser307 phosphorylation through the AMPK activation pathway.
32
Vincent Aguirre, Eric D. Werner, Jodel Giraud et al. · Journal of Biological Chemistry · 2002 · 985 citations · Full text